Stroke scare pushes patient to quit smoking
A life-threatening stroke shook John Cole into taking serious steps to improve his health – most notably he stopped smoking.
Visitor information – Everything you need to know about visiting our sites.
Our Alfred Brain program offers a full range of specialised neuroscience services, bringing together the surgical and medical neuroscience units of neurosurgery, neurology, stroke, epilepsy, multiple sclerosis and neuroimmunology (MSNI) and the Monash Alfred Psychiatric research centre (MAPrc).
Our program has two dedicated wards with over 300 clinical and research staff and 20+ outpatient clinics that care for more than 25,000 patients a year. Professor Terry O’Brien is the Director of Alfred Brain and is also Deputy Director of Research.
Our clinics are run by some of Australia’s best specialist neurologists, neurosurgeons, psychiatrists, allied health staff and specialist nurses to provide multidisciplinary treatment and care to patients with multiple neurological diseases - our patients are the focus of what we do.
The Alfred Neuroscience Clinical Trials Unit is the largest clinical trial site of its kind in Australia.
We are the only clinical trials unit with a dedicated inpatient early phase neuroscience clinical trials unit.
We have multiple platforms to enable our translational neuroscience research:
We use coded, de-identified clinical data and biological samples from our clinical services for research to provide the best treatment, quality care and outcomes for patients, establishing bio-databanks and clinical registries.
Neuroscience Bio-databank and Brain Tumour Bio-databank. Each bio-databank prospectively collects and stores tissue samples from patients with a variety of neurological diseases:
Our focus is on translational neuroscience research outcomes. We apply a ‘whole pipeline’ approach, including:
Our research is done in strong partnership with the largest academic department within the Monash University Central Clinical School, Department of Neuroscience, which commenced formally in 2018, and is a member of the Alfred Research Alliance.
Alfred Brain has several multidisciplinary collaborations within the Alfred precinct, including:
We also partner with the Monash University School of Public Health and Preventive Medicine to understand the frequency and risk factors of brain diseases, as well as the costs associated with providing health treatments.
We maintain extensive collaborations with clinical and basic neuroscience researchers at:
Our researchers have also developed strong international relationships with collaborators across the world, including undertaking joint projects, international registry studies, grant applications, and supervising medical, doctoral and postdoctoral students.
Two major collaborations include:
Our clinicians and researchers also have strong partnerships with consumers and consumer support organisations, including:
We are also a member of the Monash Central Clinical School Consumer and Research Engagement (CARE) Program.
Eight advanced epilepsy surgery cases with stereo electro-encephalography (SEEG) were performed at The Alfred, led by Dr Andrew Neal and A/Prof Martin Hunn:
The Alfred Neuroscience research team are leaders in their fields, with decades of Australian and international experience.
Prof O'Brien is the Program Director Alfred Brain, Deputy Director of Research and Head of Neuroscience Clinical Trials Unit at The Alfred.
Prof Patrick Kwan is the Director of Epilepsy: Genomics, Personalised Medicine at Alfred Health.
Dr Elspeth Hutton is the Deputy Director of Neurology and Head of Headache, Neuromuscular and Pain at Alfred Health.
A/Prof Anneke Van Der Walt is the Director of Multiple Sclerosis and Neuroimmunology at Alfred Health.
A/Prof Mastura Monif is the Head of Neuroimmunology and Neuroinflammation at Alfred Health.
Prof Geoffrey Cloud is the Director of Stroke at Alfred Health.
Dr Kelly Bertram is the Head of Movement Disorders at Alfred Health.
A/Prof David Darby in the Lead for Dementia Trials at Alfred Health.
Prof Helmut Butzkueven is the Director of Neurology and MS Trials at Alfred Health.
Lasocki, A.; Rosenthal, M. A.; Roberts-Thomson, S. J.; Neal, A.; Drummond, K. J.
(2020), AM J NEURORADIOL, 41(11), 1982-1988
DOI: 10.3174/ajnr.A6769
Fambiatos, Adam; Jokubaitis, Vilija; Horakova, Dana; Kubala Havrdova, Eva; Trojano, Maria; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Lugaresi, Alessandra; Izquierdo, Guillermo; Grand’Maison, Francois; Grammond, Pierre; Sola, Patrizia; Ferraro, Dian
(2020), MULT SCLER J, 26(1), 79-90
Ye, Karena; Foster, Emma; Johnstone, Benjamin; Carney, Patrick; Velakoulis, Dennis; O'Brien, Terence J.; Malpas, Charles B.; Kwan, Patrick
(2020), EPILEPSY RES, 163), 106342
A life-threatening stroke shook John Cole into taking serious steps to improve his health – most notably he stopped smoking.